Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
37,648,372
-
Share change
-
+5,871,339
-
Total reported value
-
$18,385,903
-
Put/Call ratio
-
0%
-
Price per share
-
$0.49
-
Number of holders
-
45
-
Value change
-
+$2,589,908
-
Number of buys
-
21
-
Number of sells
-
24
Institutional Holders of AGILE THERAPEUTICS INC - COM (AGRX) as of Q4 2021
As of 31 Dec 2021,
AGILE THERAPEUTICS INC - COM (AGRX) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,648,372 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, INVESTOR AB, D. E. Shaw & Co., Inc., BlackRock Inc., MILLENNIUM MANAGEMENT LLC, GSA CAPITAL PARTNERS LLP, GEODE CAPITAL MANAGEMENT, LLC, NEEDHAM INVESTMENT MANAGEMENT LLC, and STATE STREET CORP.
This page lists
45
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.